Lianyu Shan

Winnipeg, MB, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications

Correction: Long pentraxin 3 (PTX3) regulates IL-17A-mediated secondary immunity to Leishmania major infection in mice.

Correction: Long pentraxin 3 (PTX3) regulates IL-17A-mediated secondary immunity to Leishmania major infection in mice.

Journal: Frontiers in immunology
Published: February 26, 2026

Semaphorin 3E regulates the response of regulatory T cells to lipopolysaccharide-induced systemic inflammation.

Semaphorin 3E regulates the response of regulatory T cells to lipopolysaccharide-induced systemic inflammation.

Journal: ImmunoHorizons
Published: January 23, 2026

Long pentraxin 3 (PTX3) regulates IL-17A-mediated immunity to Leishmania major infection in mice.

Long pentraxin 3 (PTX3) regulates IL-17A-mediated immunity to Leishmania major infection in mice.

Journal: Frontiers in immunology
Published: November 05, 2025

Pentraxin 3 deficiency exacerbates neutrophilic inflammation and airway hyperresponsiveness in type 2-low asthma.

Pentraxin 3 deficiency exacerbates neutrophilic inflammation and airway hyperresponsiveness in type 2-low asthma.

Journal: Frontiers in allergy
Published: October 23, 2025

Semaphorin3E is a novel regulator of germinal center responses in a mouse model of allergic asthma.

Semaphorin3E is a novel regulator of germinal center responses in a mouse model of allergic asthma.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: June 25, 2025

TSLPR deficiency attenuates AHR independently of eosinophilia and mucus secretion in a chronic HDM mouse model of allergic asthma.

TSLPR deficiency attenuates AHR independently of eosinophilia and mucus secretion in a chronic HDM mouse model of allergic asthma.

Journal: PloS one
Published: June 17, 2025

The dichotomous impacts of Semaphorin3E deficiency on exacerbating airway hyperresponsiveness, remodelling, and inflammation in type-2 low and type-2 high asthma models.

The dichotomous impacts of Semaphorin3E deficiency on exacerbating airway hyperresponsiveness, remodelling, and inflammation in type-2 low and type-2 high asthma models.

Journal: PloS one
Published: March 20, 2025

Semaphorin 3E-Plexin D1 Axis Drives Lung Fibrosis through ErbB2-Mediated Fibroblast Activation.

Semaphorin 3E-Plexin D1 Axis Drives Lung Fibrosis through ErbB2-Mediated Fibroblast Activation.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 15, 2024

Expression of Semaphorin3E/PlexinD1 in human airway smooth muscle cells of patients with COPD.

Expression of Semaphorin3E/PlexinD1 in human airway smooth muscle cells of patients with COPD.

Journal: American journal of physiology. Lung cellular and molecular physiology
Published: September 24, 2024

CD11c+ dendritic cells PlexinD1 deficiency exacerbates airway hyperresponsiveness, IgE and mucus production in a mouse model of allergic asthma.

CD11c+ dendritic cells PlexinD1 deficiency exacerbates airway hyperresponsiveness, IgE and mucus production in a mouse model of allergic asthma.

Journal: PloS one
Published: February 20, 2024

Targeting the Semaphorin3E-plexinD1 complex in allergic asthma.

Targeting the Semaphorin3E-plexinD1 complex in allergic asthma.

Journal: Pharmacology & therapeutics
Published: March 31, 2022

PlexinD1 Deficiency in Lung Interstitial Macrophages Exacerbates House Dust Mite-Induced Allergic Asthma.

PlexinD1 Deficiency in Lung Interstitial Macrophages Exacerbates House Dust Mite-Induced Allergic Asthma.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: January 28, 2021
Showing 1-12 of 38

Last Updated: 09/26/2026